ReviewJournal of Zhejiang University. Science. B2022

Relapse after CAR-T cell therapy in B-cell malignancies: challenges and future approaches.

Tianning Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.